Selective peroxisome proliferator-activated receptor δ isosteric selenium agonists as potent anti-atherogenic agents in vivo

Bioorganic & Medicinal Chemistry Letters
2010.0

Abstract

We report the synthesis and in vivo activity of a novel anti-atherogenic agent, isosteric selenium PPARδ-selective ligand. This ligand did not cause significant body or liver weight changes and did not have obvious adverse effects on intestinal polyp formation. Our overall results clearly demonstrate that PPARδ is a viable drug candidate for targeting and treating atherosclerosis.

Knowledge Graph

Similar Paper

Selective peroxisome proliferator-activated receptor δ isosteric selenium agonists as potent anti-atherogenic agents in vivo
Bioorganic & Medicinal Chemistry Letters 2010.0
Selenium bioisosteric replacement of adenosine derivatives promoting adiponectin secretion increases the binding affinity to peroxisome proliferator-activated receptor δ
Bioorganic & Medicinal Chemistry 2020.0
Novel selective small molecule agonists for peroxisome proliferator-activated receptor δ (PPARδ)—synthesis and biological activity
Bioorganic & Medicinal Chemistry Letters 2003.0
Identification and Synthesis of a Novel Selective Partial PPARδ Agonist with Full Efficacy on Lipid Metabolism In Vitro and In Vivo
Journal of Medicinal Chemistry 2007.0
Synthesis of a novel human PPARδ selective agonist and its stimulatory effect on oligodendrocyte differentiation
Bioorganic & Medicinal Chemistry Letters 2011.0
Structure–activity relationship studies of non-carboxylic acid peroxisome proliferator-activated receptor α/δ (PPARα/δ) dual agonists
Bioorganic & Medicinal Chemistry 2016.0
Biological evaluation of novel benzisoxazole derivatives as PPARδ agonists
Bioorganic & Medicinal Chemistry 2011.0
Synthesis and Evaluation of PPARδ Agonists That Promote Osteogenesis in a Human Mesenchymal Stem Cell Culture and in a Mouse Model of Human Osteoporosis
Journal of Medicinal Chemistry 2021.0
Pharmacophore elucidation of phosphoiodyn A – Potent and selective peroxisome proliferator-activated receptor β/δ agonists with neuroprotective activity
Bioorganic & Medicinal Chemistry Letters 2016.0
Picrasidine N Is a Subtype-Selective PPARβ/δ Agonist
Journal of Natural Products 2016.0